The growth of mobile technology is now recognised by the pharmaceutical industry as an opportunity to change the way we interact with patients during clinical …
Because doctors and patients rely on the information and tools around cure, ensuring quality and safety are of paramount importance in gaining their trust in …
Mobile devices and apps are set to become an essential part of clinical trials. Their connectivity, along with high processing speeds, high-quality visual displays, and …
It is estimated that over half of the global population owns a mobile phone, and with 680 million active mobile users of Facebook each month …
Paediatric trials are a core part of clinical development. Not only is there a commercial incentive to develop paediatric treatments, but there is also a …
Asthma bronchiale is the most common and most frequent chronic illness in childhood. The global prevalence of paediatric asthma has continuously increased over the past …
Children account for 20-40% of the global population depending on the region, but only a third of all medications are officially approved to treat children. …
For more than two decades, central laboratories have played an important part in running global and large multi-regional clinical trials in Europe and the United …
The economy of Mauritius has been successfully transitioned from a monocrop to a diversified innovation-driven and knowledge-based economy. Emerging sectors such as healthcare and life …
Clinical research has a long history in South Africa and dates back as far as the 1960s. Over the past two to three decades, as …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
